John Poyhonen
Chief Financial Officer, Senomyx.
Companies
- HERON THERAPEUTICS, INC. /DE/President Oct 15, 2020 to Apr 17, 20231
- HERON THERAPEUTICS, INC. /DE/EVP, Chief Commercial Officer Jul 17, 2019 to Dec 23, 20192
- HERON THERAPEUTICS, INC. /DE/Board member Jan 21, 2014 to Dec 23, 20193
- SenomyxBoard member Jan 17, 2014 to Nov 2, 20184
- SenomyxChief executive officer Jan 17, 2014 to Nov 2, 20184
- SenomyxPresident Mar 1, 2011 to Nov 2, 20185
- SenomyxVP Chf Fin. Off. & Bus Off. Jan 18, 2006 to Apr 17, 20136
- SenomyxChief operating officer Oct 15, 2009 to Mar 1, 20117
- SenomyxChief financial officer Mar 2, 2006 to Feb 18, 20098
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- HERON THERAPEUTICS, INC. /DE/ HRTX46,648 shares9$17.7K at $0.38Apr 13, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 13, 2023Shares withheld for tax 2,012 shares at $2.88 of HERON THERAPEUTICS, INC. /DE/9
- Apr 13, 2023Exercised options 4,564 shares of HERON THERAPEUTICS, INC. /DE/9
- Apr 13, 2023Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/9
- Jan 13, 2023Shares withheld for tax 2,012 shares at $3.17 of HERON THERAPEUTICS, INC. /DE/10
- Jan 13, 2023Exercised options 4,564 shares of HERON THERAPEUTICS, INC. /DE/10
- Jan 13, 2023Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/10
- Oct 13, 2022Shares withheld for tax 2,012 shares at $3.76 of HERON THERAPEUTICS, INC. /DE/11
- Oct 13, 2022Exercised options 4,564 shares of HERON THERAPEUTICS, INC. /DE/11
- Oct 13, 2022Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/11
- Jul 13, 2022Shares withheld for tax 2,012 shares at $3.01 of HERON THERAPEUTICS, INC. /DE/12
- Jul 13, 2022Exercised options 4,564 shares of HERON THERAPEUTICS, INC. /DE/12
- Jul 13, 2022Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/12
- Apr 13, 2022Shares withheld for tax 2,012 shares at $6.07 of HERON THERAPEUTICS, INC. /DE/13
- Apr 13, 2022Exercised options 4,564 shares of HERON THERAPEUTICS, INC. /DE/13
- Apr 13, 2022Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/13
- Jan 13, 2022Shares withheld for tax 2,012 shares at $8.30 of HERON THERAPEUTICS, INC. /DE/14
- Jan 13, 2022Exercised options 4,564 shares of HERON THERAPEUTICS, INC. /DE/14
- Jan 13, 2022Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/14
- Oct 29, 2021Other 817 shares at $9.36 of HERON THERAPEUTICS, INC. /DE/15
- Oct 13, 2021Shares withheld for tax 433 shares at $10.55 of HERON THERAPEUTICS, INC. /DE/16
- Oct 13, 2021Exercised options 1,250 shares of HERON THERAPEUTICS, INC. /DE/16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARSenomyx, Board member
- 5SEC EDGARSenomyx, President
- 6SEC EDGARSenomyx, VP Chf Fin. Off. & Bus Off.
- 7SEC EDGARSenomyx, Chief operating officer
- 8SEC EDGARSenomyx, Chief financial officer
- 9
- 10SEC EDGARForm 4 filed Jan 17, 2023
- 11SEC EDGARForm 4 filed Oct 17, 2022
- 12SEC EDGARForm 4 filed Jul 15, 2022
- 13SEC EDGARForm 4 filed Apr 15, 2022
- 14SEC EDGARForm 4 filed Jan 14, 2022
- 15SEC EDGARForm 4 filed Dec 23, 2021
- 16SEC EDGARForm 4 filed Oct 15, 2021